Compare Target Corporation (TGT) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Target Corporation vs TransMedics Group Inc — how do they compare? Target Corporation trades at $138.64 (market cap $63.40B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Target Corporation is far larger — about 25× TransMedics Group Inc's market cap, and Target Corporation pays a 3.32% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TGT | TMDX | |
|---|---|---|
Market Cap | $63.40B | $2.54B |
Sector | Consumer Cyclical | Technology |
52-Week High | $141.19 | $150.42 |
52-Week Low | $83.68 | $61.99 |
Enterprise Value | $78.70B | $2.94B |
Dividend Yield | 3.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
